Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
Clinical trial NCT01712828 · COMPLETED
Trial details
- NCT number
- NCT01712828
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.